Recognising immune-related adverse reactions to immune checkpoint inhibitors – A guide for Emergency Medicine doctors
Over the last decade, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment, but are associated with immune related adverse reactions (irARs) which can impact a wide variety of body organs or systems.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Dr. George Plunkett
Dr. Megan Lyle
Duration
1 H